Product mentioned on podcasts
TB-500
Mentioned on 2 episodes by 2 guests across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
“BPC-157, TB-500, and EDR lack confirmed receptors, likely modulating gene transcription epigenetically or altering protein interactions.”
Mentioned on: Huberman Lab“seven peptides—including BPC-157 and TB-500—are scheduled for re-legalization review in July 2025.”
Mentioned on: The Diary of a CEO